Clinical Trials for Relapsed Cancer

For patients with relapsed, refractory, or recurrent cancer, early phase clinical trials may be a treatment option. Phase I and phase II clinical trials provide access to the newest, most innovative therapies to patients.

Our team is dedicated to offering state-of-the-art therapies, advancing the science of pediatric research, and providing personalized care to you and your family. We have a large portfolio of early phase clinical trials relevant to children with brain tumors, solid tumors, leukemia, and lymphoma. We are a core member of the Children’s Oncology Group Pediatric Early Phase – Clinical Trial Network (PEP-CTN), one of only 21 such centers in the United States and the only one in New England.

Our currently active phase I and phase II trials for patients with relapsed, recurrent, or refractory cancer can be found using this search tool:

Search for Enrolling Clinical Trials

If you have questions about which trial might be right for your child or patient, please email us at clinicaltrials@danafarberbostonchildrens.org or call us at 1-855-320-2090. We can help you navigate your options.